About DenComm
DenComm is a company based in Seoul (South Korea) founded in 2017.. DenComm has raised $11.98 million across 2 funding rounds from investors including KB Securities, DSC Investment and Hana Financial Group. DenComm offers products and services including Densper™. DenComm operates in a competitive market with competitors including SmarterDx, TORTUS, Saykara, Sopris Health and Clinicassist, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.98 M (USD)
in 2 rounds
-
Latest Funding Round
$7.49 M (USD), Series A
Feb 22, 2024
-
Investors
KB Securities
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DenComm
DenComm offers a comprehensive portfolio of products and services, including Densper™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI engine for voice-based dental charting with high accuracy and efficiency.
Funding Insights of DenComm
DenComm has successfully raised a total of $11.98M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $7.49 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $7.5M
-
First Round
First Round
(01 Nov 2022)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Series A - DenComm | Valuation |
investors |
|
| Nov, 2022 | Amount | Series A - DenComm | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DenComm
DenComm has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include KB Securities, DSC Investment and Hana Financial Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Early-stage venture capital is invested primarily in South Korean startups.
|
Founded Year | Domain | Location | |
|
Online trading platform for stocks, ETFs, equity, and power
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DenComm
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DenComm
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Dencomm Comparisons
Competitors of DenComm
DenComm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SmarterDx, TORTUS, Saykara, Sopris Health and Clinicassist, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based clinical charting software is developed for healthcare organizations.
|
|
| domain | founded_year | HQ Location |
AI co-pilot for clinicians is provided in healthcare sector.
|
|
| domain | founded_year | HQ Location |
Patient documentation is automated for physicians using machine learning.
|
|
| domain | founded_year | HQ Location |
Patient-doctor communications are recorded and scribed by the AI platform.
|
|
| domain | founded_year | HQ Location |
Offers AI-powered medical charting software for doctors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about DenComm
When was DenComm founded?
DenComm was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Where is DenComm located?
DenComm is headquartered in Seoul, South Korea.
Who is the current CEO of DenComm?
Byeongjun Lim is the current CEO of DenComm.
Is DenComm a funded company?
DenComm is a funded company, having raised a total of $11.98M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.49M, raised on Nov 01, 2022.
What does DenComm do?
AI-powered voice recognition solutions for the dental industry. The company has developed Densper, an AI voice recognition engine tailored specifically for dental practices such as voice charting, multilingual consultation and voice viewer controller.
Who are the top competitors of DenComm?
What products or services does DenComm offer?
DenComm offers Densper™.
Who are DenComm's investors?
DenComm has 5 investors. Key investors include KB Securities, DSC Investment, Hana Financial Group, Stassets Investment, and TS Investment.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.